Case Report of Non-small Cell Lung Cancer Patient with EGFR T790M Mutation Treated with Th ird Generation Inhibitor
Keyword(s):
Lung cancer treatment based on the molecular classifi cation of the tumor has paved the way for multiple lines of targeted treatment, even though the development of resistance remains a major cause of concern. Epidermal growth factor receptor (EGFR) remains the poster boy for the use of targeted therapy, and the presence/absence of mutations in this gene has led to the development of inhibitors targeting specifi c mutations. We present the case of an advanced non-small cell lung cancer patient with EGFR T790M mutation treated with Osimertinib, a third-generation inhibitor.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol Volume 10
◽
pp. 2289-2295
◽
Keyword(s):
2006 ◽
Vol 61
(6)
◽
pp. 591
◽
Keyword(s):
2019 ◽
Vol 144
(11)
◽
pp. 2880-2886
◽
Keyword(s):